Fed. Circ. Finds Boehringer's Mirapex Patent Valid
A federal appeals court has handed a win to German pharmaceutical company Boehringer Ingelheim International GmbH, reversing a 2008 ruling that invalidated a patent related to the company's Parkinson's disease treatment...To view the full article, register now.
Already a subscriber? Click here to view full article